002773 Chengdu Kanghong Pharmaceutical Group
- 19.82
- -0.52-2.56%
Chengdu Kanghong Pharmaceutical Group News
Kanghong Pharmaceutical: Announcement on the Company\'s Receipt of the Drug Clinical Trial Approval Notice
Kanghong Pharmaceutical: Announcement on Using Own Funds to Purchase Wealth Management Products
Kanghong Pharmaceutical: Announcement on the resignation of the company\'s senior management
Kanghong Pharmaceutical: Announcement on Using Own Funds to Purchase Wealth Management Products
Chengdu Kanghong Pharmaceutical Group: Financial Report for the first half of 2024.
Chengdu Kanghong Pharmaceutical Group: Interim financial statements.
Chengdu Kanghong Pharmaceutical Group: Summary table of non-operating funds utilization and other related funds flow for the first half of the year.
Chengdu Kanghong Pharmaceutical Group: Announcement Regarding the Company's Receipt of Pharmaceutical Registration Certificate.
Chengdu Kanghong Pharmaceutical Group: Announcement regarding the subsidiary receiving notification of approval for the listing application of chemical raw materials.
Chengdu Kanghong Pharmaceutical Group: Announcement regarding the subsidiary receiving notification of approval for the listing application of chemical raw materials.
Chengdu Kanghong Pharmaceutical Group: Announcement regarding the completion of commercial registration changes and the revision of the company's articles of association.
Chengdu Kanghong Pharmaceutical Group: Articles of Association (revised in December 2023).
Chengdu Kanghong Pharmaceutical Group: Announcement regarding receipt of the Pharmaceutical Registration Certificate from the Food and Drugs Administration of the Ministry of Health of the Republic of the Union of Myanmar.
Chengdu Kanghong Pharmaceutical Group: Announcement Regarding the Use of Own Funds to Purchase Wealth Management Products.
Chengdu Kanghong Pharmaceutical Group: Announcement Regarding the Use of Own Funds to Purchase Wealth Management Products.
Chengdu Kanghong Pharmaceutical Group: Announcement Regarding the Company's Receipt of Pharmaceutical Registration Certificate for Pralofan Eye Drops.
Chengdu Kanghong Pharmaceutical Group: Announcement on using own funds to purchase wealth management products
Chengdu Kanghong Pharmaceutical Group: Legal Opinion of Beijing Commerce (Shenzhen) Law Firm on the 2023 Annual General Meeting of Shareholders of Chengdu Kanghong Pharmaceutical Group Co., Ltd.
Chengdu Kanghong Pharmaceutical Group: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
Chengdu Kanghong Pharmaceutical Group: Notice on the subsidiary receiving a notice of approval for drug clinical trials
Analysis
Price Target
No Data
No Data